Glaxosmithkline Plc Progyny, Inc. (PGNY) insider trading activity

GLAXOSMITHKLINE PLC Transaction History

Date	Transaction	Value	Shares Traded	Form
May 20 2020	SELL Open market or private sale	$103,000,000 $25.75 p/Share	4,000,000
Oct 29 2019	BUY Conversion of derivative security	-	9,821,190

Also insider at

CRSP

CRISPR Therapeutics AG Healthcare

> 10% Shareholder

SPRO

Spero Therapeutics, Inc. Healthcare

> 10% Shareholder

TBIO

Translate Bio, Inc. Healthcare

> 10% Shareholder

LQDA

Liquidia Technologies Inc

PRNB

Principia Biopharma Inc.

CCXI

ChemoCentryx, Inc.

TPTX

Turning Point Therapeutics, Inc.

Director

BCYC

BICYCLE THERAPEUTICS plc Healthcare

> 10% Shareholder

GNCA

GENOCEA BIOSCIENCES, INC. Healthcare

> 10% Shareholder

MORF

Morphic Holding, Inc. Healthcare

Director

FULC

Fulcrum Therapeutics, Inc. Healthcare

NKTX

Nkarta, Inc. Healthcare

Director

PAND

Pandion Therapeutics, Inc.

Director

DBTX

Decibel Therapeutics, Inc. Healthcare

Director

INVA

Innoviva, Inc. Healthcare

> 10% Shareholder

LYEL

Lyell Immunopharma, Inc. Healthcare

> 10% Shareholder

CVRX

CVRx, Inc. Healthcare

> 10% Shareholder

TBPH

Theravance Biopharma, Inc. Healthcare

WVE

Wave Life Sciences Ltd. Healthcare

> 10% Shareholder